VU Venture Partners — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Nutromicsnutromics.comin𝕏Sep 2022 · $14M
Nutromics is developing a wearable patch for continuous, real-time monitoring of biomarkers in hospital settings, starting with therapeutic drug monitoring of the antibiotic vancomycin.
BiotechDeep TechDigital HealthHealthtechMedical DevicesMelbourne, AU
Peter Vranes(Co-Founder & CEO)inHitesh Mehta(COO & Co-Founder)inGarry Chambers(Co-Founder)inJustin Gooding(Chief Scientific Officer)Rowan(CFO)
Co-investorsArtesianCP VenturesMedTech Actuator
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




